Which gastrointestinal disease is characterized by abdominal pain, bloating, intermittent diarrhea, recurrent oral aphthous ulcers, and an ulcerative lesion on the elbow?

Behçet's Disease

The clinical presentation of abdominal pain, bloating, intermittent diarrhea, oral aphthous ulcers, and an ulcerative lesion on the elbow is most consistent with Behçet's disease, a multisystem inflammatory vasculitis that commonly involves the gastrointestinal tract.

Clinical Reasoning

This constellation of symptoms represents the classic triad of Behçet's disease plus gastrointestinal involvement:

• Oral aphthous ulcers: The hallmark feature present in virtually all cases 1
• Skin lesions (ulcerative lesion on elbow): Consistent with the cutaneous manifestations of Behçet's disease 2
• Gastrointestinal symptoms: Abdominal pain, bloating, and intermittent diarrhea indicate GI involvement, which occurs in a significant subset of patients 3

Why Behçet's Disease Over Inflammatory Bowel Disease?

While Crohn's disease can present with similar GI symptoms and oral ulcers, the presence of a specific ulcerative skin lesion on the elbow strongly points toward Behçet's disease rather than IBD. The combination of recurrent oral aphthous ulcers with extraintestinal skin manifestations and GI symptoms is pathognomonic for Behçet's disease 4, 3.

Key distinguishing features:

• Behçet's disease characteristically presents with recurrent oral and genital ulcers, uveitis, and skin lesions as major symptoms 2
• GI involvement in Behçet's typically affects the ileocecal region with deep penetrating ulcers 1, 3
• The skin lesions in Behçet's are distinct from the erythema nodosum or pyoderma gangrenosum seen in IBD

Diagnostic Approach

There are no pathognomonic laboratory tests for Behçet's disease—diagnosis relies on clinical criteria 3. Look for:

1. Recurrent oral ulceration (mandatory criterion)
2. Plus two of the following:
   • Recurrent genital ulceration
   • Eye lesions (uveitis, retinal vasculitis)
   • Skin lesions (erythema nodosum, pseudofolliculitis, papulopustular lesions)
   • Positive pathergy test

Gastrointestinal Evaluation

• Colonoscopy with ileoscopy to identify characteristic deep penetrating ulcers, most commonly in the ileocecal region 3
• The ulcers in Behçet's tend to be single or multiple, deep, and penetrating—different from the continuous inflammation of ulcerative colitis or skip lesions of Crohn's 1

Critical Pitfall

Do not delay treatment while waiting for complete diagnostic workup if clinical suspicion is high. Gastrointestinal Behçet's disease is associated with significant morbidity and mortality, particularly when deep ulcers perforate 1, 3.

Treatment Strategy

Based on EULAR recommendations 1:

For Gastrointestinal Involvement:

Initiate immunosuppressive therapy immediately, except in surgical emergencies:

1. First-line agents (try before surgery):

   • Corticosteroids (systemic)
   • Sulfasalazine
   • Azathioprine 1

2. Refractory cases:

   • TNF-α antagonists (infliximab)
   • Thalidomide 1

3. Maintenance therapy:

   • Azathioprine should be continued as maintenance to decrease re-operation rates in patients who require surgery 1

Important Treatment Principles:

• Medical treatment with immunosuppressives should be tried first before surgery, except for emergencies such as perforation 1
• The deep penetrating ulcers characteristic of Behçet's GI involvement tend to perforate, requiring emergency procedures like ileocolectomy with high recurrence rates 1
• Corticosteroids are the cornerstone of acute management and showed good response in case reports 4

Monitoring and Prognosis

• Methods for monitoring disease activity exist but are imperfect 3
• A subset of patients have a poor disease course, particularly those with vascular, CNS, or severe GI involvement 2
• Close surveillance is essential as GI involvement is associated with significant morbidity and mortality 3

Geographic Consideration

Behçet's disease prevalence is highest along the ancient Silk Road (Mediterranean to East Asia), with lower prevalence in North America and Northern Europe 3. However, the diagnosis should not be excluded based on geography alone when clinical features are compelling.